Pages that link to "Q33561185"

The following pages link to Immunophenotypic analysis of AIDS-related diffuse large B-cell lymphoma and clinical implications in patients from AIDS Malignancies Consortium clinical trials 010 and 034 (Q33561185):

Displaying 36 items.

• How I treat HIV-associated lymphoma (Q26821860) (← links)
• Newly emerging therapies targeting viral-related lymphomas (Q33699201) (← links)
• The role of macrophages in the development and progression of AIDS-related non-Hodgkin lymphoma (Q33805288) (← links)
• The role of tumor histogenesis, FDG-PET, and short-course EPOCH with dose-dense rituximab (SC-EPOCH-RR) in HIV-associated diffuse large B-cell lymphoma (Q33805988) (← links)
• Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma (Q33806007) (← links)
• Diffuse large B cell lymphoma: using pathologic and molecular biomarkers to define subgroups for novel therapy. (Q33846801) (← links)
• Pathology of lymphoma in HIV. (Q34020069) (← links)
• How do viruses trick B cells into becoming lymphomas? (Q34020096) (← links)
• The significance of FOXP1 in diffuse large B-cell lymphoma (Q34047455) (← links)
• Bortezomib-induced Epstein-Barr virus and Kaposi sarcoma herpesvirus lytic gene expression: oncolytic strategies (Q34245230) (← links)
• A20 (TNFAIP3) genetic alterations in EBV-associated AIDS-related lymphoma. (Q35001620) (← links)
• Immunostaining to identify molecular subtypes of diffuse large B-cell lymphoma in a population-based epidemiologic study in the pre-rituximab era. (Q35193836) (← links)
• The tumor virus landscape of AIDS-related lymphomas (Q35607311) (← links)
• The role of the tumor microenvironment in HIV-associated lymphomas (Q35945221) (← links)
• mTOR activity in AIDS-related diffuse large B-cell lymphoma (Q36278593) (← links)
• Pegylated liposomal doxorubicin, rituximab, cyclophosphamide, vincristine, and prednisone in AIDS-related lymphoma: AIDS Malignancy Consortium Study 047 (Q36490052) (← links)
• Epstein-Barr virus infection and expression of B-cell oncogenic markers in HIV-related diffuse large B-cell Lymphoma (Q37355725) (← links)
• Classification of AIDS-related lymphoma cases between 1987 and 2012 in Japan based on the WHO classification of lymphomas, fourth edition. (Q37595265) (← links)
• Molecular characteristics of diffuse large B-cell lymphoma in human immunodeficiency virus-infected and -uninfected patients in the pre-highly active antiretroviral therapy and pre-rituximab era. (Q37605365) (← links)
• mTOR signaling and drug development in cancer (Q37710367) (← links)
• Gammaherpesvirus and lymphoproliferative disorders in immunocompromised patients (Q37865141) (← links)
• Clinical implications of the molecular subtypes of diffuse large B-cell lymphoma (Q37944927) (← links)
• Diagnosis and management of lymphomas and other cancers in HIV-infected patients (Q38194845) (← links)
• Therapy of HIV-associated lymphoma-recommendations of the oncology working group of the German Study Group of Physicians in Private Practice Treating HIV-Infected Patients (DAGNÄ), in cooperation with the German AIDS Society (DAIG). (Q38210131) (← links)
• Relevance of miR-21 in HIV and non-HIV-related lymphomas. (Q38222875) (← links)
• Clinical management of HIV-associated hematologic malignancies (Q38664912) (← links)
• Non-AIDS-related malignancies: expert consensus review and practical applications from the multidisciplinary CANCERVIH Working Group (Q38673153) (← links)
• Determining protein biomarkers for DLBCL using FFPE tissues from HIV negative and HIV positive patients. (Q39329062) (← links)
• HIV-associated lymphoma sub-type distribution, immunophenotypes and survival in an urban clinic population (Q40284342) (← links)
• Clinicopathological characteristics and rituximab addition to cytotoxic therapies in patients with rheumatoid arthritis and methotrexate-associated large B lymphoproliferative disorders (Q41645710) (← links)
• Immunohistochemical expression profile and prognosis in patients with diffuse large B-cell lymphoma with or without human immunodeficiency virus infection (Q45372503) (← links)
• Safety and Preliminary Efficacy of Vorinostat With R-EPOCH in High-risk HIV-associated Non-Hodgkin's Lymphoma (AMC-075). (Q50092086) (← links)
• Expression of immunohistochemical markers in patients with AIDS-related lymphoma (Q50962592) (← links)
• HIV-1 and the macrophage (Q55967625) (← links)
• HIV AND LYMPHOMA: FROM EPIDEMIOLOGY TO CLINICAL MANAGEMENT (Q60923192) (← links)
• Identifying transcriptional profiles and evaluating prognostic biomarkers of HIV-associated diffuse large B-cell lymphoma from Malawi (Q89811270) (← links)